Cornelis Networks Appoints Lisa Spelman as CEO

Company Taps Data Center and AI Industry Veteran to Accelerate Growth in Enterprise- and Cloud-scale AI Market WAYNE, Pa. – Cornelis Networks, a leading independent provider of intelligent, high-performance networking solutions, today announced the appointment of Lisa Spelman as its new chief executive officer (CEO), effective August 15. Spelman joins Cornelis from Intel Corporation, where she held executive leadership roles for more than two decades, … Continue reading Cornelis Networks Appoints Lisa Spelman as CEO

Impact Newswire23/07/202423/07/2024

Africa

Access Bank Joins NGX to Launch Impact Board

Jul 22, 2024 Access Bank Plc, Nigeria’s leading institution in sustainable finance, was one of the participants in the launch of the Nigerian Exchange Limited (NGX) Impact Board, a dedicated platform for listing sustainability instruments to integrate sustainability into the core of Nigeria’s capital market. The event, marked by the attendance of high-profile stakeholders, including the Minister of Environment, Balarabe Lawal, and the Director-General of … Continue reading Access Bank Joins NGX to Launch Impact Board

Impact Newswire22/07/202424/07/2024

United States

General Mills Names Asheesh Saksena Chief Strategy & Growth Officer

MINNEAPOLIS – General Mills (NYSE: GIS) today announced Asheesh Saksena has been named Chief Strategy & Growth Officer, effective Aug. 26, 2024. He will report to Jeff Harmening, Chairman and CEO, join the Senior Leadership Team, and have global accountability for the company’s comprehensive strategic planning process and for building long-term, sustainable plans and capabilities to accelerate growth. Saksena succeeds Dana McNabb, following her prior … Continue reading General Mills Names Asheesh Saksena Chief Strategy & Growth Officer

Impact Newswire22/07/202422/07/2024

Untied Kingdom

Mogrify Appoints Dr Jonathan Appleby as Chief Scientific Officer

Strategic hire bolsters executive leadership team as Company progresses multiple therapeutic programs toward and into clinical development. CAMBRIDGE, England – Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies for diseases with high unmet clinical need, announces the appointment of Dr Jonathan Appleby as Chief Scientific Officer. With decades of industry experience in translating both conventional and advanced therapeutic medicines, … Continue reading Mogrify Appoints Dr Jonathan Appleby as Chief Scientific Officer

Impact Newswire22/07/202422/07/2024